MDHearing VoltMax vs Signia Pure C&G BCT IX

The MDHearing VoltMax is a behind-the-ear OTC hearing aid priced at $699, earning a B grade with a SoundScore of 3.0/5 in our lab testing. This places it in the lower tier of the OTC hearing aid category, ranking 62nd out of 65 devices tested. In our testing, the VoltMax delivered mixed results across key performance areas. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5—above the category average by 0.46 points. This means users can expect stable performance without whistling or squealing during typical daily activities. However, speech clarity proved challenging, with speech-in-quiet scoring 1.9/5 (0.93 points below category average) and speech-in-noise at 1.0/5 (0.48 points below average). Own-voice comfort measured 2.4/5, slightly below the category norm. A significant limitation is music streaming, which scored 0.0/5—nearly 2 points below the category average. Users who prioritize phone streaming for calls or media should consider alternatives. The device features rechargeable batteries, offering convenience over disposable options. At this price point, several competitors deliver substantially stronger overall performance. The VoltMax may appeal to budget-conscious consumers who primarily need basic amplification with reliable feedback control and don't require streaming capabilities. Those seeking better speech clarity or music streaming should explore higher-scoring options in this price range.

The Signia Pure C&G BCT IX is a premium behind-the-ear prescription hearing aid released in 2025, earning an A grade with a SoundScore of 4.4/5 in our lab testing. Priced at $3,398, it ranks #16 among 39 prescription hearing aids tested. In our standardized testing, this device demonstrates particular strength in own-voice comfort, scoring 3.8/5—a solid result that sits 1.10 points above the category average. This makes it a noteworthy option for users who prioritize natural sound quality when speaking. Speech clarity also performs well, with speech-in-quiet at 3.8/5 (+0.39 points above average) and speech-in-noise at 2.5/5 (+0.43 points above average), though the latter remains mixed in absolute terms despite beating the category benchmark. Feedback handling presents an interesting picture: at 4.2/5, it's strong in absolute terms, though it falls 0.52 points below the category average of 4.72/5. Music streaming scores 2.7/5, essentially matching the category average. The device features rechargeable batteries, iPhone and Android streaming, and hands-free functionality. While the Pure C&G BCT IX delivers solid overall performance, shoppers in this premium price tier should note that competitors like the Phonak Sphere Infinio and Oticon Intent score higher in our testing. Budget-conscious buyers may also find comparable sound quality at lower price points from options like the Rexton Reach R-Li T80 at Costco. This hearing aid is best suited for users who value own-voice naturalness and reliable speech clarity in everyday listening situations.